paxilline has been researched along with Meningeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balavenkatraman, KK; Böhmer, FD; Friedrich, S; Gührs, KH; Haase, D; Mawrin, C; Nakamura, M; Petermann, A; Tenev, T; Wetzel, A | 1 |
1 other study(ies) available for paxilline and Meningeal Neoplasms
Article | Year |
---|---|
Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Gene Knockdown Techniques; Humans; Immunoblotting; Immunohistochemistry; Loss of Heterozygosity; Meningeal Neoplasms; Meningioma; Mice; Mice, Nude; Neoplasm Invasiveness; Paxillin; Polymerase Chain Reaction; Receptor-Like Protein Tyrosine Phosphatases, Class 3; RNA, Small Interfering; Signal Transduction; Transfection | 2011 |